drugset / Trial / NCT03065816

Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

NCT03065816 ↗

Phase 1 Completed 34 enrolled Sanofi
RandomizedCrossoverOpen-labelBasic science

Summary

Primary Objective: Pharmacodynamics: assessment and comparison by gamma scintigraphy of the gastric retention of alginate rafts (raft performance) of Z0063 to the effect of Gaviscon Double Action Tablets, in healthy adult subjects. Secondary Objective: Safety: assessment of the clinical safety of Z0063 versus Gaviscon Double Action tablets, in healthy adult subjects.

Timeline

Start
2017-02-09
Primary completion
2017-05-02
Completion
2017-05-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gaviscon Unknown — Oral
Subject Z0063 Unknown — Oral